DUBLIN, April 10, 2019 /PRNewswire/ -- The "Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The global live cell encapsulation market is projected to reach USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2%.
The growth of this market is majorly driven by factors such as the ongoing technological advancements in live cell encapsulation, growing public-private investments in the field of live cell encapsulation, increasing number of target patient population, and the rising awareness related to the clinical role of encapsulated cells in disease management. However, the limited availability of high-quality raw materials, and the significant adoption of alternative therapies are expected to restrain the growth of this market during the forecast period.
"The electrostatic dripping segment to witness the highest growth rate in the live cell encapsulation market, by manufacturing technique"
Based on manufacturing technique, the live cell encapsulation market is segmented into simple dripping, electrostatic dripping, coaxial airflow, liquid-jet break-up, vibrating-jet technique, jet cutting, and rotating disk atomization. The electrostatic dripping segment is expected to account for the high growth rate of this market in 2018, owing to the growing demand for electrostatic dripping as a result of the procedural benefits such as retention of cell viability & potency, and preservation of plant oxidants.
"Alginate segment to witness the highest growth rate in the live cell encapsulation market, by polymer type"
Based on polymer type, the live cell encapsulation market has been segmented into alginate, HEMA-MMA (hydroxyethyl methacrylate-methyl methacrylate), chitosan, siliceous encapsulates, cellulose sulfate, PAN-PVC [poly (acrylonitrile vinyl chloride)], and other polymers. The alginate segment is estimated to grow at the highest CAGR during the forecast period majorly due to the procedural benefits offered such as the capability to encapsulate living cells with wide pore size distribution (5-200 nm) and high permeability of alginate.
"The drug therapy segment to account for the largest share of the live cell encapsulation market, by application, in 2018"
Based on application, the live cell encapsulation market is segmented into drug delivery, regenerative medicine, cell transplantation, probiotics, and research. The drug delivery segment is expected to account for the largest share of the live cell encapsulation market in 2018. The growth of this application segment can be attributed to the rising incidence of target diseases and increasing research activities on live cell encapsulation in major countries across the globe.
"The North America market to grow at the highest CAGR during the forecast period"
The live cell encapsulation market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The North America market is expected to grow at the highest CAGR during the forecast period majorly due to the increasing research activities in the field of cell encapsulation coupled with the growing public-private investments for cell encapsulation research practices.
Furthermore, the increasing clinical data for the efficacy of the cell encapsulation technique and the rising adoption of cell encapsulation techniques among medical professionals are the other factors supporting the growth of this market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Live Cell Encapsulation Market Overview
4.2 Europe: Live Cell Encapsulation Market, By Polymer Type
4.3 Global Live Cell Encapsulation Market, By Technique
4.4 Live Cell Encapsulation Market, By Application
4.5 Live Cell Encapsulation Market, By Country
5 Market Overview
5.2 Market Dynamics
126.96.36.199 Increasing Incidence of Target Diseases
188.8.131.52 Focus on Novel Drug Delivery Systems for Disease Treatment
184.108.40.206 Technology Advancements
220.127.116.11 Increasing Public-Private Investments to Support Novel Product Development
18.104.22.168 Rising Public Awareness Related to the Clinical Role of Encapsulated Cells in Disease Management
22.214.171.124 High Product Manufacturing Costs
126.96.36.199 Limited Market Availability of High-Quality Raw Materials
188.8.131.52 Rising Research Activity
184.108.40.206 Adoption of Alternative Therapies
6 Live Cell Encapsulation Market, By Manufacturing Techniques
6.2 Simple Dripping
6.2.1 Global Live Cell Encapsulation: Market Split for Simple Dripping Technique, By Application
6.3 Electrostatic Dripping
6.3.1 Global Live Cell Encapsulation: Market Split for Electrostatic Dripping Technique, By Application
6.4 Coaxial Airflow
6.4.1 Global Live Cell Encapsulation: Market Split for Coaxial Airflow Technique, By Application
6.5 Liquid-Jet Break-Up
6.5.1 Global Live Cell Encapsulation: Market Split for Liquid Jet Break Up Technique, By Application
6.6 Vibrating-Jet Technique
6.6.1 Global Live Cell Encapsulation: Market Split for Vibrating Jet Technique, By Application
6.7 Jet Cutting
6.7.1 Global Live Cell Encapsulation: Market Split for Jet Cutting Technique, By Application
6.8 Rotating Disk Atomization
6.8.1 Global Live Cell Encapsulation: Market Split for Rotating Disk Atomization Technique, By Application
7 Live Cell Encapsulation Market, By Polymer Type
7.2.1 Alginate is the Most Widely Adopted Material for the Encapsulation of Living Cells
7.3.1 Hema-Mma-Based Products are Used Mainly for Liver Transplantation Procedures and Diabetes Management
7.4.1 Inadequate Availability of Natural Chitosan Sources is Expected to Hamper Market Growth
7.5 Siliceous Encapsulates
7.5.1 Procedural Benefits Offered By Siliceous Encapsulates Such as Effective Process Control & High Process Adjustability to Drive Market Growth
7.6 Cellulose Sulfate
7.6.1 Techno-Commercial Benefits Such as High Mechanical Stability & Adjustability to Drive Market Growth
7.7.1 PAN-PVC Polymers Have Mechanical Stability, Permeability, and High Biocompatibility
7.8 Other Polymers
8 Live Cell Encapsulation Market, By Application
8.2 Drug Delivery
8.2.1 Drug Delivery Forms the Largest Application Segment of the Live Cell Encapsulation Market
8.3 Regenerative Medicine
8.3.1 Clinical Risk of Clogging in the Hepatic Vascular System is Expected to Hamper the Adoption of Cell Encapsulation for Regenerative Medicine
8.4 Cell Transplantation
8.4.1 Increasing Incidence of Target Diseases & Technological Advancements in the Field of Cell Transplantation to Support Market Growth
8.5.1 Probiotics Applications to Register the Highest Growth During the Forecast Period
8.6.1 Growing Awareness About the Research Applications of Cell Encapsulation Techniques and the Increasing Availability of Public-Private Funding, Investments, & Grants to Drive Market Growth
9 Live Cell Encapsulation Market, By Region
10 Competitive Landscape
10.2 Global Market Share Analysis (2017)
10.3 Competitive Scenario (2015 to 2019)
10.4 Competitive Leadership Mapping
11 Company Profiles
- Balchem Corporation
- Biotime, Inc.
- Blacktrace Group
- BUCHI Labortechnik AG
- Encapsys, LLC
- Evonik Industries
- Living Cell Technologies
- Merck KGaA
- Neurotech Holdings, LLC.
- Reed Pacific Pty Limited
- Sernova Corporation
- Sigilon Therapeutics
- Viacyte, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/nrn4pf
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets